Milestone Pharmaceuticals
Focus: Milestone Pharmaceuticals is a Montreal-based specialty pharmaceutical company focused on small-molecule therapeutics in neurology, with a clinical-stage pipeline centered on etripamil for cardiac arrhythmias.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Open Jobs
1
Should You Work at Milestone Pharmaceuticals?
AI assessmentBest suited for clinical-stage professionals willing to work in a lean organization with a focused cardiac pipeline and early-stage commercial execution.
Why Work Here
- CARDAMYST (etripamil) is in active commercial launch phase with a 2042 LOE, offering opportunity to build market presence in a validated mechanism for PSVT treatment.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Launch15.8yr
L-type calcium channel inhibitor approved for acute PSVT termination; first non-IV treatment option in this indication with long exclusivity runway.
Help build intelligence for Milestone Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.